精确
发表于 2025-3-23 13:06:41
http://reply.papertrans.cn/39/3830/382927/382927_11.png
淡紫色花
发表于 2025-3-23 14:06:33
http://reply.papertrans.cn/39/3830/382927/382927_12.png
obnoxious
发表于 2025-3-23 21:19:53
https://doi.org/10.1007/978-3-663-04586-1ostly in relation to leukemia and lymphoma, and their association with epithelial tumors is discovered very poorly. Nevertheless, these correlations may be found (. gene polymorphisms, cervical cancer, and esophageal cancer; . gene polymorphisms and breast cancer; . gene polymorphisms and colorectal cancer risk).
Contort
发表于 2025-3-23 23:18:46
Structural Genomic Variation in Toll-Like Receptor Signaling Pathway and Cancer,ostly in relation to leukemia and lymphoma, and their association with epithelial tumors is discovered very poorly. Nevertheless, these correlations may be found (. gene polymorphisms, cervical cancer, and esophageal cancer; . gene polymorphisms and breast cancer; . gene polymorphisms and colorectal cancer risk).
growth-factor
发表于 2025-3-24 03:52:27
http://reply.papertrans.cn/39/3830/382927/382927_15.png
Aqueous-Humor
发表于 2025-3-24 08:59:48
http://reply.papertrans.cn/39/3830/382927/382927_16.png
Ablation
发表于 2025-3-24 10:52:07
http://reply.papertrans.cn/39/3830/382927/382927_17.png
你敢命令
发表于 2025-3-24 17:59:16
Pattern Recognition Receptors, Gene Polymorphisms, and Cancer: A Double-Edged Sword,ecognition receptors with structural genomic variation and with cancer. Here we describe a hypothesis of « double-edged sword » , which is based on the mechanisms of association between TLR and NLR polymorphisms and cancer.
cultivated
发表于 2025-3-24 22:07:48
http://reply.papertrans.cn/39/3830/382927/382927_19.png
tenosynovitis
发表于 2025-3-25 02:21:27
The Biology of Toll-Like Receptors and NOD-Like Receptors: The Toggles of Inflammation,pattern recognition receptors, namely NOD-like receptors. However, here we focus only on NOD1 and NOD2 due to their special relevance for the applied genomics. We describe the structure of these receptors, then we consider cells where they are expressed, their ligands, and, finally, depict a scheme